Table 3.
Relationship between expression of Ki67 and clinicopathological parameters in gastric cancer
| Variable | Cases | Positive (%) | Negative (%) | χ2 | P value |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 28 | 18 (64%) | 10 (36%) | 0.686 | 0.408 |
| Female | 12 | 10 (83%) | 2 (17%) | ||
| Age | |||||
| ≤60 | 18 | 12 (95%) | 6 (5%) | 0.005 | 0.945 |
| >60 | 22 | 16 (95%) | 6 (5%) | ||
| Differentiation | |||||
| High | 12 | 8(67%) | 4 (33%) | ||
| Median | 14 | 10 (71%) | 4 (29%) | ||
| Low | 14 | 10 (71%) | 4 (29%) | 0.027 | 0.870 |
| Stage | |||||
| I/II | 12 | 6 | 6 | 1.695 | 0.193 |
| III/IV | 28 | 20 | 8 | ||
| LN metastasis | |||||
| Positive | 26 | 18 | 8 | 0.584 | 0.445 |
| Negative | 14 | 8 | 6 |